Published in
Taylor and Francis Group, Leukemia & Lymphoma, 8(56), p. 2315-2325
DOI: 10.3109/10428194.2014.982635
Links
Tools
Cost-effectiveness of the sequential application of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia
Journal article published in 2015 by
Ursula Rochau,
Gaby Sroczynski 
,
Dominik Wolf,
Stefan Schmidt,
Beate Jahn ,
Martina Kluibenschaedl,
Annette Conrads-Frank,
David Stenehjem ,
Diana Brixner,
Jerald Radich,
Günther Gastl,
Uwe Siebert
,
Dominik Wolf,
Stefan Schmidt,
Beate Jahn ,
Martina Kluibenschaedl,
Annette Conrads-Frank,
David Stenehjem ,
Diana Brixner,
Jerald Radich,
Günther Gastl,
Uwe Siebert
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 